If BIO achieved $5m for the first five months and Q1 was reported as $2.74 then the monthly sales rate for Oct and Nov was $1.13 per month giving them a run rate of $13.56 pa. Even if that run rate remains flat for the rest of the year that would get them to $12.91 for the full year which would exceed their guidance of $11.5. The sales in Oct/Nov show about a 23% growth quarter on quarter so if BIO keeps growing at that same rate the full year result could be even higher.
Looking very good to me but do your own research
Ann: Revenue Update, page-6
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
58.0¢ |
Change
0.060(11.5%) |
Mkt cap ! $124.7M | |||
| Open | High | Low | Value | Volume |
| 54.0¢ | 58.5¢ | 53.0¢ | $1.045M | 1.858M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2260 | 57.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.0¢ | 4539 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| BIO (ASX) Chart |